Notice2023-14703
Reorganization of the National Center on Birth Defects and Developmental Disabilities
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
July 12, 2023
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Abstract
CDC has modified its structure. This notice announces the reorganization of the National Center on Birth Defects and Developmental Disabilities (NCBDDD). NCBDDD realigned the Office of Genomics and Precision Public Health from the Office of Science to the NCBDDD, retitled and made mission and functional statements updates to some organizational entities.
Full Text
<html>
<head>
<title>Federal Register, Volume 88 Issue 132 (Wednesday, July 12, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 132 (Wednesday, July 12, 2023)]
[Notices]
[Pages 44343-44344]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-14703]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Reorganization of the National Center on Birth Defects and
Developmental Disabilities
AGENCY: Centers for Disease Control and Prevention (CDC), the
Department of Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: CDC has modified its structure. This notice announces the
reorganization of the National Center on Birth Defects and
Developmental Disabilities (NCBDDD). NCBDDD realigned the Office of
Genomics and Precision Public Health from the Office of Science to the
NCBDDD, retitled and made mission and functional statements updates to
some organizational entities.
DATES: This reorganization was approved by the Director of CDC on June
28, 2023.
FOR FURTHER INFORMATION CONTACT: Kimberly Thurmond, Office of the Chief
Operating Officer, Office of the Director, Centers for Disease Control
and Prevention, 1600 Clifton Road NE, MS TW-2, Atlanta, GA 30329.
Telephone 770-488-4401; Email: <a href="/cdn-cgi/l/email-protection#3143545e435642715255521f565e47"><span class="__cf_email__" data-cfemail="2d5f48425f4a5e6d4e494e034a425b">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: Part C (Centers for Disease Control and
Prevention) of the Statement of Organization, Functions, and
Delegations of Authority of the Department of Health and Human Services
(45 FR 67772-76, dated October 14, 1980, and corrected at 45 FR 69296,
October 20, 1980, as amended most recently at 88 FR 9290-9291, dated
February 13, 2023) is amended to reflect the reorganization of the
National Center on Birth Defects and Developmental Disabilities,
Centers for Disease Control and Prevention. Specifically, the changes
are as follows:
I. Under Part C, Section C-B, Organization and Functions, insert
the following:
<bullet> National Center on Birth Defects and Developmental
Disabilities (CF)
<bullet> Office of the Director (CF1)
<bullet> Resource Management Office (CF12)
<bullet> Division of Birth Defects and Infant Disorders (CFB)
<bullet> Office of the Director (CFB1)
<bullet> Birth Defects Monitoring and Research Branch (CFBB)
<bullet> Infant Outcomes Monitoring, Research and Prevention Branch
(CFBC)
<bullet> Division of Human Development and Disability (CFC)
<bullet> Office of the Director (CFC1)
<bullet> Child Development and Disability Branch (CFCB)
<bullet> Disability and Health Promotion Branch (CFCC)
<bullet> Division of Blood Disorders (CFD)
<bullet> Office of the Director (CFD1)
<bullet> Epidemiology and Surveillance Branch (CFBD)
<bullet> Hemostasis Laboratory Branch (CFDC)
<bullet> Public Health Genomics Branch (CFDD)
II. Under Part C, Section C-B, Organization and Functions, retitle
the following organizational units:
<bullet> Division of Blood Disorders (CFD) to the Division of Blood
Disorders and Public Health Genomics (CFD)
<bullet> Epidemiology and Surveillance Branch (CFBD) to the Blood
Disorders Surveillance and Epidemiology Branch (CFBD)
III. Under Part C, Section C-B, Organization and Functions, delete
the mission or functional statements for and replace with the
following:
National Center on Birth Defects and Developmental Disabilities
(CF). The mission of the National Center on Birth Defects and
Developmental Disabilities (NCBDDD) is to improve the health of
children and adults by preventing birth defects and developmental
disabilities, and complications of heredity blood disorders; promoting
optimal child development, and the health and wellness among children
and adults living with disabilities and those living with or at risk of
genetic disorder across the lifespan. NCBDDD strives to prevent disease
save healthcare costs and reduce health disparities in the United
States. In carrying out this mission, this organization: (1) conducts
public health research, epidemiological investigations, genomic
research, laboratory research, demonstration projects and public health
programs; (2) plans, develops, establishes, and maintains systems of
surveillance and monitoring the population for these conditions; (3)
operates regional centers for the conduct of applied epidemiological
research on these conditions; (4) provides information and education to
healthcare providers, public health professionals, and the public on
these conditions; (5) provides technical assistance, consultation,
capacity building through technology transfer, grants, cooperative
agreements, contracts, and other means to state, local, international,
and nonprofit organizations to prevent and control these conditions;
(6) provides training in the epidemiology of these conditions for
healthcare professionals within and outside the United States; (7)
translates scientific findings into intervention, prevention, and
health promotion strategies; (8) conducts evaluations of programs to
determine effectiveness; and (9) coordinates activities with other CDC
organizations and Federal and non-Federal health agencies, as
appropriate.
After item 4 of the Office of the Director (CF1) functional
statement, insert the following:
Office of the Director (CF1). (5) coordinates with medical,
scientific, and other professional organizations interested in birth
defects prevention, genetics, developmental disabilities prevention,
and disabilities and health, and prevention of complications of
hereditary blood disorders.
[[Page 44344]]
After item 4 of the Division of Birth Defects and Infant Disorders
(CFB1) functional statement, insert the following:
Division of Birth Defects and Infant Disorders (CFB1). (5) provides
assistance to state and local health departments on community exposures
to teratogenic, mutagenic, embryotoxic, other environmental agents, and
genetic influences adversely interfering with normal growth and
development.
Office of the Director (CFD1). (1) provides leadership and guidance
on strategic planning and implementation, program priority setting, and
policy development, to advance the mission of the division, NCBDDD, and
CDC; (2) develops goals, objectives, and the budget; monitors progress
and allocation of resources, and reports accomplishments, future
directions, and resource requirements, (3) facilitates scientific,
policy and program collaboration among divisions and centers, and
between CDC and other Federal/non-Federal partners; (4) promotes the
advancement of science throughout the division, supports program
evaluation, and ensures that research meets the highest standards in
the field; (5) provides medical expertise and consultation to planning,
projects, policies and program activities; (6) advises the NCBDDD
Office of the Director on matters relating to blood disorders and
genomics and coordinates division responses to requests for technical
assistance or information on activities supported by the division; (7)
develops and produces communications tools and public affairs
strategies to meet the needs of division programs and mission; and (8)
represents the division at official professional and scientific
meetings, both within and outside of CDC.
IV. Under Part C, Section C-B, Organization and Functions, add the
following functional statements:
Public Health Genomics Branch (CFDD). (1) identifies and evaluates
emerging genomic, family health history, and precision health
applications with the potential to impact population health by
preventing disease, saving healthcare costs, and reducing health
disparities in the United States; (2) integrates advances in human
genomics, machine learning, data science, and predictive analytics
responsibly and effectively into public health programs and healthcare;
(3) provides technical assistance and advice to CDC leadership and
programs, other Federal agencies, state health departments, and other
external partners by identifying, evaluating, and implementing
evidence-based genomics and precision health practices to prevent and
control the country's leading genetic diseases; (4) supports policy,
education, and surveillance frameworks to promote effective
implementation of evidence-based recommendations for genomic tests,
family health history, and precision health applications, as well as
those applications that will emerge in the future; and (5) conducts
genomics and epidemiologic studies and analyses to improve public
health.
V. Under Part C, Section C-B, Organization and Functions, the
following organizational unit is deleted in its entirety:
<bullet> Office of Public Health Genomics and Precision Public Health
(CPPE) within the Office of Science (CPP)
Delegations of Authority
All delegations and redelegations of authority made to officials
and employees of affected organizational components will continue in
them or their successors pending further redelegation, provided they
are consistent with this reorganization.
(Authority: 44 U.S.C. 3101)
Robin D. Bailey, Jr.,
Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2023-14703 Filed 7-11-23; 8:45 am]
BILLING CODE 4163-18-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on July 12, 2023.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.